# Implantation or Injectable Dosage Form New Animal Drugs; Polysulfated Glycosaminoglycan
> **Food and Drug Administration** · Final rule. · Published 2009-12-21 · Effective 2009-12-21 · 74 FR 67815
## Document
- **Document number:** E9-30222
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 74 FR 67815
- **CFR reference:** 21 CFR 522
- **Publication date:** 2009-12-21
- **Effective date:** 2009-12-21
- **HHS docket:** Docket No. FDA-2009-N-0665
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Luitpold Pharmaceuticals, Inc. The supplemental NADA provides for additional vial sizes for an injectable solution of polysulfated glycosaminoglycan.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2009/12/21/E9-30222/implantation-or-injectable-dosage-form-new-animal-drugs-polysulfated-glycosaminoglycan)
---
*AI Analytics · CC0 1.0*